Wikisage, the free encyclopedia of the second generation, is digital heritage
West's syndrome: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
mNo edit summary |
||
| Line 15: | Line 15: | ||
*Chung S S. 2015. A review of the efficacy and safety of extended-release topiramate in the adjunctive treatment for refractory partial-onset seizure [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409552/pdf/10.1177_1756285615578406.pdf Therapeutic Advances in Neurological Disorders (3):131-6. doi: 10.1177/1756285615578406.] | *Chung S S. 2015. A review of the efficacy and safety of extended-release topiramate in the adjunctive treatment for refractory partial-onset seizure [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409552/pdf/10.1177_1756285615578406.pdf Therapeutic Advances in Neurological Disorders (3):131-6. doi: 10.1177/1756285615578406.] | ||
{{refs}} | |||
{{wikidata|Q1041258}} | |||
Revision as of 22:38, 18 May 2019
Disease classification WHO
G40.4 Epileptic spams
West's syndrome or epileptic spams is a rare condition of adult and children, it is related with Lennox–Gastaut syndrome ACTH was considered effective in treating infantile spams. [1][2] [3]Prolonged prenatal stress or prenatal administration of corticosteroids may significantly alter seizure susceptibility [4]
Links
Helena Gaufin et al.2015 Being parents with epilepsy: thoughts on its consequences and difficulties affecting their children Neuropsychiatic Disease and Treatment ;11:1291-8. doi: 10.2147/NDT.S74222. eCollection 2015.
- Chung S S. 2015. A review of the efficacy and safety of extended-release topiramate in the adjunctive treatment for refractory partial-onset seizure Therapeutic Advances in Neurological Disorders (3):131-6. doi: 10.1177/1756285615578406.
